Optimizing antipseudomonal therapy in critical care

Area of Science:

• Medical Microbiology
• Infectious Diseases
• Critical Care Medicine

Background:

• Pseudomonas aeruginosa is a prevalent and significant pathogen in critically ill patients.
• Its environmental hardiness and genomic plasticity facilitate adaptation to intensive care unit (ICU) niches.
• Antibiotic resistance is a growing concern, impacting treatment strategies like monotherapy versus dual therapy.

Purpose of the Study:

• To review the factors contributing to Pseudomonas aeruginosa success in the ICU.
• To discuss emerging alternative strategies for managing this pathogen.
• To provide practical insights into antibiotic prescribing in the ICU.

Main Methods:

• This is a review article, synthesizing existing knowledge.
• It focuses on understanding the underlying issues of P. aeruginosa infections in ICUs.
• Emphasis is placed on practical aspects of antibiotic prescribing.

Main Results:

• Pseudomonas aeruginosa exhibits remarkable adaptability to the ICU environment.
• Increasing antibiotic resistance necessitates exploration of alternative therapeutic approaches.
• The debate between monotherapy and dual therapy is ongoing, concerning killing speed and resistance development.

Conclusions:

• Understanding P. aeruginosa's adaptability and resistance mechanisms is crucial for effective ICU management.
• Alternative treatment strategies are needed due to increasing conventional antibiotic resistance.
• Optimizing antibiotic prescribing practices in the ICU is essential for patient outcomes.